Ernexa Therapeutics Inc. ERNA
Set alert
1.97 USD -0.14 -6.64%
At close · Oct 30
2.30 +0.33 +16.75%
After hours · Oct 30, 4:00 PM ET
1.97 Day range 2.14
1.94 52-week range 47.00
- YTD
- -93.43%
- 1 year
- -95.57%
- Open
- 2.14
- Prev close
- 2.11
- Mkt cap
- 3.22M
- Vol
- 4.49K
- Avg vol
- 50.65K
- EPS
- -13.63
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.97
- High
- 2.14
- Forward P/E
- -0.03
- Beta
- 7.77
- Short ratio
- 1.07
- Inst. own
- 11.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.7302
- 200-d avg
- 1.58
- 1y target
- 0.00
Financial health
Altman Z-Score
-64.60 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 3
Valuation
P/E -0.5×
FY 2016 5y median -6.0× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 3.2×
FY 2016 5y median 64.3× FY 2025
P/FCF -1.1×
FY 2016 5y median -7.0× FY 2025
EV/EBITDA -0.4×
FY 2016 5y median -5.8× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -93.2%
FY 2016 5y median -14.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -586.6%
FY 2016 5y median -586.6% FY 2025
ROIC -316.6%
FY 2016 5y median -316.6% FY 2025
ROA -241.4%
FY 2016 5y median -241.4% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2016 FY 2025
Operating Income 40.5%
FY 2016 FY 2025
EPS (diluted) -42.7%
FY 2016 FY 2025
Free Cash Flow 56.5%
FY 2016 FY 2025
Financial Health
Current Ratio 1.0×
FY 2016 5y median 1.5× FY 2025
Quick Ratio 1.0×
FY 2016 5y median 1.5× FY 2025
Debt / Equity 0.2×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA 0.1×
FY 2016 5y median 0.1× FY 2025
Interest Coverage -345×
FY 2016 5y median -345× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median -0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31